HALOZYME THERAPEUTICS, INC.

HALONasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$1.4B

▲ 37.6% YoY

Net Income

$316.9M

▼ 28.6% YoY

EPS

$2.56

▼ 25.4% YoY

Cash

$133.8M

▲ 15.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.